Allotype imbalance or microsatellite mutation in low-grade soft tissue sarcomas of the extremities in adults Journal Article


Authors: Cho, N. H.; Cordon-Cardo, C.; Li, G. C.; Kim, S. H.
Article Title: Allotype imbalance or microsatellite mutation in low-grade soft tissue sarcomas of the extremities in adults
Abstract: The ability to repair DNA double-strand breaks is essential to maintain chromosomal stability. Virtually all soft tissue sarcomas contain chromosomal instabilities, including clonal aberrations and cytogenetic aberrations. However, the relevance of DNA-dependent protein kinase (DNA-PK) in the pathogenesis of soft tissue sarcoma has not been clarified. The main aim of this work is to compare the prognostic impact of genotypic imbalance in lowgrade soft tissue sarcomas of the extremities, and to correlate this with the translational level of DNA-PK. This study investigated 28 adult low-grade malignant spindle cell tumours of the extremities, predominantly fibrosarcomas, for loss of heterozygosity (LOH) and microsatellite mutation on flanking regions of each DNA-PK subunit, with identical immunophenotypes. Twelve different polymorphic markers flanking the specific loci of three subunits comprise the genetic map of DNA-PK, at 22q13, 2q35, and 8q11. Translational activity was also analysed by western blot and conventional immunohistochemistry. The overall sarcoma 5-year survival rate was 61.7%. LOH was identified in the specific coding region of DNA-PK in 39.29% for the DNA-PK catalytic subunit (cs), 17.86% for Ku70, and only 7.14% for Ku80. A positive LOH for DNA-PKcs was shown to be a significant factor for poor survival (log rank test p = 0.0160). Immunoreactivity and immunoblot results correlated with the loss of DNA-PKcs allotype in soft tissue sarcoma (Fisher's exact test p = 0.0037). Ku70 and DNA-PKcs were almost identical in terms of immunoreactivity. In conclusion, whereas microsatellite mutation seems an uncommon event during the evolution of low-grade fibrosarcoma of the extremities in adults, the loss of DNA-PKcs defines a biologically more aggressive subset. Copyright © 2002 John Wiley & Sons, Ltd.
Keywords: immunohistochemistry; adolescent; adult; clinical article; controlled study; aged; aged, 80 and over; middle aged; survival rate; unclassified drug; gene mutation; mutation; dna-binding proteins; pathogenesis; follow-up studies; cancer grading; dna repair; gene locus; genotype; cytogenetics; immunoreactivity; dna strand breakage; nuclear proteins; sarcoma; chromosome aberration; gene mapping; blotting, western; correlation analysis; fibrosarcoma; protein-serine-threonine kinases; western blotting; dna, neoplasm; immunoblotting; limb tumor; soft tissue sarcoma; rna translation; protein biosynthesis; immunophenotyping; dna flanking region; heterozygosity loss; protein subunit; spindle cell sarcoma; ku antigen; loss of heterozygosity; genetic code; fisher exact test; soft tissue neoplasms; marker gene; chromosome 8q; microsatellite repeats; enzyme active site; chromosome 22q; molecular stability; chromosome 2q; dna dependent protein kinase; dna-activated protein kinase; ku; catalytic subunit; humans; prognosis; human; male; female; priority journal; article; ku80 protein; allotype; dna-protein kinase
Journal Title: Journal of Pathology
Volume: 198
Issue: 1
ISSN: 0022-3417
Publisher: Wiley Blackwell  
Date Published: 2002-09-01
Start Page: 21
End Page: 29
Language: English
DOI: 10.1002/path.1177
PUBMED: 12210059
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 14 November 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gloria C Li
    132 Li